BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · Real-Time Price · USD
23.43
+0.08 (0.34%)
Feb 11, 2026, 4:00 PM EST - Market closed
BrainsWay Market Cap
BrainsWay has a market cap or net worth of $459.52 million as of February 12, 2026. Its market cap has increased by 137.49% in one year.
Market Cap
459.52M
Enterprise Value
390.92M
1-Year Change
137.49%
Ranking
Category
Stock Price
$23.43
Market Cap Chart
Since September 3, 2013, BrainsWay's market cap has increased from $178.92M to $459.52M, an increase of 156.82%. That is a compound annual growth rate of 7.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 459.52M | 19.71% |
| Dec 31, 2025 | 383.87M | 112.82% |
| Dec 31, 2024 | 180.37M | 70.88% |
| Dec 31, 2023 | 105.55M | 216.46% |
| Dec 29, 2022 | 33.35M | -73.96% |
| Dec 30, 2021 | 128.06M | 62.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Varex Imaging | 570.52M |
| Cytek Biosciences | 557.49M |
| Perspective Therapeutics | 555.90M |
| Pacific Biosciences of California | 555.51M |
| Bioventus | 541.17M |
| Orthofix Medical | 534.60M |
| NeuroPace | 484.96M |
| Standard BioTools | 457.63M |